Skip to main content

Les douleurs dans la sclérose en plaques

Pain in multiple sclerosis

Résumé

La douleur concerne environ deux tiers des patients présentant une sclérose en plaques. Elle peut être classée en différentes catégories: neuropathique centrale (continue ou paroxystique), céphalées, musculosquelettiques, en lien avec une névrite optique et secondaire à l’utilisation des traitements de fond. Une analyse précise de l’étiologie douloureuse permet de mettre en place un traitement optimal. Malgré les traitements disponibles actuellement, certains patients ne sont pas soulagés et le développement de nouvelles prises en charge antalgiques semble nécessaire.

Abstract

Pain is present in around 2/3 of patients with multiple sclerosis. It can be classified as: central neuropathic (either continuous or paroxysmal), headaches, musculoskeletal, related to optic neuritis and related to disease modifying treatments. Defining acurately the type of pain is mandatory to give the most adapted treatment. Despite pharmacological treatments currently available, several patients are not relieved and the development of new treatments is still necessary.

This is a preview of subscription content, access via your institution.

Références

  1. Foley PL, Vesterinen HM, Laird BJ, et al (2013) Prevalence and natural history of pain in adults with multiple sclerosis: Systematic review and meta-analysis. Pain 154:632–42

    Article  PubMed  Google Scholar 

  2. Brochet B, Deloire MS, Ouallet JC, et al (2009) Pain and quality of life in the early stages after multiple sclerosis diagnosis: a 2- year longitudinal study. Clin J Pain 25:211–7

    Article  PubMed  Google Scholar 

  3. Moisset X, Ouchchane L, Guy N, et al (2013) Migraine headaches and pain with neuropathic characteristics: comorbid conditions in patients with multiple sclerosis. Pain 154:2691–9

    Article  PubMed  Google Scholar 

  4. Grasso MG, Clemenzi A, Tonini A, et al (2008) Pain in multiple sclerosis: a clinical and instrumental approach.Mult Scler 14:506–13

  5. Yamout B, Issa Z, Herlopian A, et al (2013) Predictors of quality of life among multiple sclerosis patients: a comprehensive analysis. Eur J Neurol 20:756–64

    CAS  Article  PubMed  Google Scholar 

  6. Piwko C, Desjardins OB, Bereza BG, et al (2007) Pain due to multiple sclerosis: analysis of the prevalence and economic burden in Canada. Pain Res Manag 12:259–65

    Article  PubMed  PubMed Central  Google Scholar 

  7. O’Connor AB, Schwid SR, Herrmann DN, et al (2008) Pain associated with multiple sclerosis: systematic review and proposed classification. Pain 137:96–111

    Article  PubMed  Google Scholar 

  8. Truini A, Barbanti P, Pozzilli C, Cruccu G (2012) A mechanismbased classification of pain in multiple sclerosis. J Neurol 260:351–67

    Article  PubMed  PubMed Central  Google Scholar 

  9. Svendsen KB, Jensen TS, Overvad K, et al (2003) Pain in patients with multiple sclerosis: a population-based study. Arch Neurol 60:1089–94

    Article  PubMed  Google Scholar 

  10. Heitmann H, Biberacher V, Tiemann L, et al (2016) Prevalence of neuropathic pain in early multiple sclerosis. Mult Scler 22:1224–30

    Article  PubMed  Google Scholar 

  11. Bouhassira D, Lantéri-Minet M, Attal N, et al (2008) Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 136:380–7

    Article  PubMed  Google Scholar 

  12. Agostoni E, Frigerio R, Protti A (2005) Controversies in optic neuritis pain diagnosis. Neurol Sci 26(Suppl 2):s75–s78

    Article  PubMed  Google Scholar 

  13. D’Amico D, La Mantia L, Rigamonti A, et al (2004) Prevalence of primary headaches in people with multiple sclerosis. Cephalalgia 24:980–4

    Article  PubMed  Google Scholar 

  14. Nicoletti A, Patti F, Lo Fermo S, et al (2008) Headache and multiple sclerosis: a population-based case-control study in Catania, Sicily. Cephalalgia 28:1163–9

    CAS  Article  PubMed  Google Scholar 

  15. Putzki N, Pfriem A, Limmroth V, et al (2009) Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis. Eur J Neurol 16:262–7

    CAS  Article  PubMed  Google Scholar 

  16. Pakpoor J, Handel AE, Giovannoni G, et al (2012) Meta-analysis of the relationship between multiple sclerosis and migraine. PloS One 7:e45295

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  17. Gee JR, Chang J, Dublin AB, Vijayan N (2005) The association of brainstem lesions with migraine-like headache: an imaging study of multiple sclerosis. Headache 45:670–7

    Article  PubMed  Google Scholar 

  18. Zorzon M, Zivadinov R, Nasuelli D, et al (2003) Risk factors of multiple sclerosis: a case-control study. Neurol Sci 24:242–7

    CAS  Article  PubMed  Google Scholar 

  19. Kister I, Munger KL, Herbert J, Ascherio A (2012) Increased risk of multiple sclerosis among women with migraine in the Nurses’ Health Study II. Mult Scler 18:90–7

    Article  PubMed  Google Scholar 

  20. Möhrke J, Kropp P, Zettl UK (2013) Headaches in multiple sclerosis patients might imply an inflammatorial process. PloS One 8: e69570

    Article  PubMed  PubMed Central  Google Scholar 

  21. Graziano E, Hagemeier J, Weinstock-Guttman B, et al (2015) Increased contrast enhancing lesion activity in relapsingremitting multiple sclerosis migraine patients. Neuroimage Clin 9:110–6

    Article  PubMed  PubMed Central  Google Scholar 

  22. Pöllmann W, Erasmus LP, Feneberg W, et al (2002) Interferon beta but not glatiramer acetate therapy aggravates headaches in MS. Neurology 59:636–9

    Article  PubMed  Google Scholar 

  23. Fragoso YD, Adoni T, Gomes S, et al (2015) Persistent headache in patients with multiple sclerosis starting treatment with fingolimod. Headache 55:578–9

    Article  PubMed  Google Scholar 

  24. Laroni A, Brogi D, Brescia Morra V, et al (2016) Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy. Neurol Sci [in press]

  25. Welch SP, Sim-Selley LJ, Selley DE (2012) Sphingosine-1-phosphate receptors as emerging targets for treatment of pain. Biochem Pharmacol 84:1551–62

    CAS  Article  PubMed  Google Scholar 

  26. Xu Z, Zhang F, Sun F, et al (2015) Dimethyl fumarate for multiple sclerosis. Cochrane Database Syst Rev 4):CD011076

    Google Scholar 

  27. Bernardini LR, Zecca C, Clerici VT, et al (2016) Severe articular and musculoskeletal pain: An unexpected side effect of dimethylfumarate therapy for multiple sclerosis. J Neurol Sci 369:139–40

    Article  PubMed  Google Scholar 

  28. Jawahar R, Oh U, Yang S, Lapane KL (2013) A systematic review of pharmacological pain management in multiple sclerosis. Drugs 73:1711–22

    CAS  Article  PubMed  Google Scholar 

  29. Solaro C, Trabucco E, Messmer Uccelli M (2013) Pain and multiple sclerosis: pathophysiology and treatment. Curr. Neurol. Neurosci Rep 13:320

    Article  PubMed  Google Scholar 

  30. Bouhassira D, Attal N, Alchaar H, et al (2005) Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 114:29–36

    Article  PubMed  Google Scholar 

  31. Finnerup NB, Attal N, Haroutounian S, et al (2015) Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 14:162–73

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  32. Yadav V, Bever C, Bowen J, et al (2014) Summary of evidencebased guideline: complementary and alternative medicine in multiple sclerosis: report of the guideline development subcommittee of the American Academy of Neurology. Neurology 82:1083–92

    Article  PubMed  PubMed Central  Google Scholar 

  33. Solaro C, Messmer Uccelli M (2010) Pharmacological management of pain in patients with multiple sclerosis. Drugs 70:1245–54

    CAS  PubMed  Google Scholar 

  34. Headache Classification Committee of the International Headache Society (IHS) (2013) The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33: 629–808

    Article  Google Scholar 

  35. Lanteri-Minet M, Valade D, Géraud G, et al (2013) [Guidelines for the diagnosis and management of migraine in adults and children]. Rev Neurol (Paris) 169:14–29

    CAS  Article  Google Scholar 

  36. Moisset X, Mawet J, Guegan-Massardier E, et al (2016) French Guidelines For the Emergency Management of Headaches. Rev Neurol (Paris) 172:350–60

    CAS  Article  Google Scholar 

  37. Bendtsen L, Evers S, Linde M, et al (2010) EFNS guideline on the treatment of tension-type headache - report of an EFNS task force. Eur J Neurol 17:1318–25

    CAS  Article  PubMed  Google Scholar 

  38. de Seze J, Borgel F, Brudon F (2012) Patient perceptions of multiple sclerosis and its treatment. Patient Prefer. Adherence 6:263–73

    PubMed  PubMed Central  Google Scholar 

  39. Ayache SS, Palm U, Chalah MA, et al (2016) Prefrontal tDCS Decreases Pain in Patients with Multiple Sclerosis. Front. Neurosci 10:147

    Article  PubMed  PubMed Central  Google Scholar 

  40. Moisset X, Goudeau S, Poindessous-Jazat F, et al (2015) Prolonged Continuous Theta-burst Stimulation is More Analgesic Than ‘Classical’ High Frequency Repetitive Transcranial Magnetic Stimulation. Brain Stimulat 8:135–41

    Article  Google Scholar 

  41. Moisset X, de Andrade DC, Bouhassira D (2016) From pulses to pain relief: an update on the mechanisms of rTMS-induced analgesic effects. Eur J Pain 20:689–700

    CAS  Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to X. Moisset.

About this article

Verify currency and authenticity via CrossMark

Cite this article

Moisset, X., Clavelou, P. Les douleurs dans la sclérose en plaques. Douleur analg 30, 7–11 (2017). https://doi.org/10.1007/s11724-016-0475-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11724-016-0475-y

Mots clés

  • Douleur
  • Sclérose en plaques
  • Douleur neuropathique
  • Migraine

Keywords

  • Pain
  • Multiple sclerosis
  • Neuropathic pain
  • Migraine